AB Science today announced that results from masitinib study AB12005 in pancreatic cancer, have been selected for presentation at the upcoming ASCO Annual Meeting

NEXT STORY
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
PREV STORY
Live Cell Encapsulation Market Size to Reach USD 350 Million In 2028; Live cells are encased in protective capsules, sized of a headpin Says Reports and Data
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

AB Science today announced that results from masitinib study AB12005 in pancreatic cancer, have been selected for presentation at the upcoming ASCO Annual Meeting

NEXT STORY
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
PREV STORY
Live Cell Encapsulation Market Size to Reach USD 350 Million In 2028; Live cells are encased in protective capsules, sized of a headpin Says Reports and Data
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxil Announces Close of Second and Final Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $264,100

author_avatar
NASDAQ Market News

Novartis provides update on BELINDA study investigating Kymriah® as second-line treatment in aggressive B-cell non-Hodgkin lymphoma

author_avatar
NASDAQ Market News

Progenics Pharmaceuticals Announces Initiation of a Phase 1 Clinical Trial of its PSMA-Targeted Therapeutic Candidate 1095 For the Treatment of Metastatic Prostate Cancer

NEW YORK, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology ...

author_avatar
NASDAQ Market News